Altamira Therapeutics Ltd.
CYTOF
$0.10
$0.0223.63%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.80K | 3.80K | 998.60K | 998.60K | 65.50K |
| Total Receivables | 213.40K | 213.40K | 351.30K | 351.30K | 121.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 30.40K | 30.40K | 1.60K | 1.60K | 75.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 189.00K | 189.00K | 262.00K |
| Total Current Assets | 247.60K | 247.60K | 1.54M | 1.54M | 524.00K |
|
|
|||||
| Total Current Assets | 247.60K | 247.60K | 1.54M | 1.54M | 524.00K |
| Net Property, Plant & Equipment | 430.70K | 430.70K | 449.90K | 449.90K | 417.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.63M | 4.63M | 4.63M | 4.63M | 4.63M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.13M | 7.13M | 8.65M | 8.65M | 8.07M |
|
|
|||||
| Total Accounts Payable | 763.30K | 763.30K | 524.80K | 524.80K | 526.60K |
| Total Accrued Expenses | 901.90K | 901.90K | 489.90K | 489.90K | 577.90K |
| Short-term Debt | 445.40K | 445.40K | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 145.90K | 145.90K | 122.40K | 122.40K | 123.40K |
| Total Finance Division Other Current Liabilities | 53.00K | 53.00K | 27.20K | 27.20K | -- |
| Total Other Current Liabilities | 53.00K | 53.00K | 27.20K | 27.20K | -- |
| Total Current Liabilities | 2.31M | 2.31M | 1.16M | 1.16M | 1.23M |
|
|
|||||
| Total Current Liabilities | 2.31M | 2.31M | 1.16M | 1.16M | 1.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 445.40K | 445.40K | -- | -- | -- |
| Capital Leases | 198.80K | 198.80K | 238.70K | 238.70K | 304.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 548.10K | 548.10K | 684.10K | 684.10K | 218.90K |
| Total Liabilities | 3.06M | 3.06M | 2.09M | 2.09M | 1.75M |
|
|
|||||
| Common Stock & APIC | 11.40K | 11.40K | 9.30K | 9.30K | 5.30K |
| Retained Earnings | -4.04M | -4.04M | -3.03M | -3.03M | 1.26M |
| Treasury Stock & Other | 8.10M | 8.10M | 9.59M | 9.59M | 5.05M |
| Total Common Equity | 4.07M | 4.07M | 6.57M | 6.57M | 6.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.07M | 4.07M | 6.57M | 6.57M | 6.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.07M | 4.07M | 6.57M | 6.57M | 6.32M |
|
|
|||||